You are here:
NICE
NICE Guidance
Published Guidance
The clinical effectiveness and cost effectiveness of rituximab for follicular lymphoma
Technology appraisal guidance
Reference number:
TA37
Published:
27 March 2002
This guidance has been updated and replaced by
NICE technology appraisal guidance 137
.